Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer

Ann Surg Oncol. 2020 Dec;27(Suppl 3):979. doi: 10.1245/s10434-020-08688-z.

¹ Department of Surgery, University of California San Francisco, San Francisco, CA, USA. michael.alvarado@ucsf.edu.
² Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Division of Surgical Oncology, Department of Surgery, UC Davis Medical Center, Sacramento, CA, USA.
⁴ Breastcare Specialists, Allentown, PA, USA.
⁵ Dallas Surgical Group, Dallas, TX, USA.
⁶ Department of Surgery, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
⁷ Regulatory and Clinical Research Institute, Inc., Minneapolis, MN, USA.
⁸ Endomagnetics Limited, Cambridge, UK.

Abstract

In the original article the authors' disclosures were incomplete.